You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CELESTONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CELESTONE?
  • What are the global sales for CELESTONE?
  • What is Average Wholesale Price for CELESTONE?
Drug patent expirations by year for CELESTONE
Drug Prices for CELESTONE

See drug prices for CELESTONE

Recent Clinical Trials for CELESTONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Indiana Hand to Shoulder CenterPhase 2
CTM BiomedicalPhase 2
Population Health Research InstitutePhase 4

See all CELESTONE clinical trials

US Patents and Regulatory Information for CELESTONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering CELESTONE betamethasone CREAM;TOPICAL 014762-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering CELESTONE betamethasone TABLET;ORAL 012657-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering CELESTONE betamethasone sodium phosphate INJECTABLE;INJECTION 017561-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CELESTONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering CELESTONE betamethasone CREAM;TOPICAL 014762-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Schering CELESTONE betamethasone TABLET;ORAL 012657-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Merck Sharp Dohme CELESTONE betamethasone SYRUP;ORAL 014215-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.